Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo - PubMed (original) (raw)

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo

T Naveh-Many et al. J Clin Invest. 1990 Dec.

Abstract

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3 dramatically decreases parathyroid hormone (PTH) gene transcription. We have now studied the effect of 1,25(OH)2D3 on the 1,25(OH)2D receptor (VDR) in the parathyroid in vivo. Rats were injected with 1,25(OH)2D3 and the parathyroid-thyroid tissue analyzed for PTHmRNA and VDRmRNA. 1,25(OH)2D3 (50 and 100 pmol ip) decreased PTHmRNA at 6 h with a maximum at 48 h (less than 4% of basal), whereas VDRmRNA was increased only after 6 h with a 1.7-fold increase at 24 h. VDRmRNA levels peaked at 25 pmol 1,25(OH)2D3 with a twofold increase. Serum calcium did not affect VDRmRNA. Parathyroid VDRmRNA ran at 2.2 and 4.4 kb, whereas duodenum VDRmRNA had a single band, all of which increased after 1,25(OH)2D3. Weanling rats on a vitamin D-deficient diet for 3 wk had a more intense 2.2-kb transcript, whereas vitamin D-replete rats had a more intense 4.4-kb band. Dispersed parathyroid-thyroid cells were separated by a flow cytometry (FACS) into a parathyroid cell peak containing PTHmRNA and a second peak with cells positive for thyro-globulin mRNA and calcitonin mRNA. VDRmRNA was concentrated in the parathyroid cell peak. In situ hybridization of parathyroid-thyroid and duodenum for VDRmRNA showed its localization to the parathyroid cells and the duodenal mucosa. Therefore, the VDRmRNA in the parathyroid-thyroid tissue represents predominantly parathyroid cell and not C-cell VDRmRNA which is also a 1,25(OH)2D3 target organ. The increased VDR gene expression in the parathyroid cell would amplify the effect of 1,25(OH)2D3 to decrease PTH gene transcription.

PubMed Disclaimer

Cited by

Calcifediol: Mechanisms of Action.
Donati S, Palmini G, Aurilia C, Falsetti I, Marini F, Giusti F, Iantomasi T, Brandi ML. Donati S, et al. Nutrients. 2023 Oct 17;15(20):4409. doi: 10.3390/nu15204409. Nutrients. 2023. PMID: 37892484 Free PMC article. Review.
Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism.
Xiang Z, Wang M, Miao C, Jin D, Wang H. Xiang Z, et al. Front Pharmacol. 2022 Oct 4;13:1020858. doi: 10.3389/fphar.2022.1020858. eCollection 2022. Front Pharmacol. 2022. PMID: 36267284 Free PMC article. Review.
Rapid Nontranscriptional Effects of Calcifediol and Calcitriol.
Donati S, Palmini G, Aurilia C, Falsetti I, Miglietta F, Iantomasi T, Brandi ML. Donati S, et al. Nutrients. 2022 Mar 18;14(6):1291. doi: 10.3390/nu14061291. Nutrients. 2022. PMID: 35334948 Free PMC article. Review.
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
Hanudel MR, Laster ML, Portale AA, Dokras A, Quigley RP, Guzman GAL, Zaritsky JJ, Hayde NA, Kaskel FJ, Mitsnefes MM, Ramirez JA, Imani PD, Srivaths PR, Kogon AJ, Denburg MR, Blydt-Hansen TD, Reyes LZ, Greenbaum LA, Weidemann DK, Warady BA, Elashoff DA, Mendley SR, Isakova T, Salusky IB. Hanudel MR, et al. Pediatr Nephrol. 2022 Nov;37(11):2547-2557. doi: 10.1007/s00467-022-05492-7. Epub 2022 Mar 2. Pediatr Nephrol. 2022. PMID: 35237863 Free PMC article. Review.
Osteoporosis therapies and their mechanisms of action (Review).
Kim B, Cho YJ, Lim W. Kim B, et al. Exp Ther Med. 2021 Dec;22(6):1379. doi: 10.3892/etm.2021.10815. Epub 2021 Sep 28. Exp Ther Med. 2021. PMID: 34650627 Free PMC article. Review.

References

1. Biochem J. 1982 Jul 15;206(1):181-4 - PubMed
1. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9770-3 - PubMed
1. Endocrinology. 1985 Nov;117(5):2203-10 - PubMed
1. Annu Rev Genet. 1985;19:209-52 - PubMed
1. Biochem Biophys Res Commun. 1986 Jun 13;137(2):742-7 - PubMed

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo - PubMed (original) (raw)